JP2022541169A5 - - Google Patents

Info

Publication number
JP2022541169A5
JP2022541169A5 JP2022502110A JP2022502110A JP2022541169A5 JP 2022541169 A5 JP2022541169 A5 JP 2022541169A5 JP 2022502110 A JP2022502110 A JP 2022502110A JP 2022502110 A JP2022502110 A JP 2022502110A JP 2022541169 A5 JP2022541169 A5 JP 2022541169A5
Authority
JP
Japan
Prior art keywords
mir
colorectal cancer
vitro method
measuring
hemoglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022502110A
Other languages
English (en)
Japanese (ja)
Other versions
JP7727970B2 (ja
JP2022541169A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/069918 external-priority patent/WO2021009184A1/en
Publication of JP2022541169A publication Critical patent/JP2022541169A/ja
Publication of JP2022541169A5 publication Critical patent/JP2022541169A5/ja
Application granted granted Critical
Publication of JP7727970B2 publication Critical patent/JP7727970B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022502110A 2019-07-15 2020-07-14 結腸直腸癌および／またはその前癌段階の診断またはスクリーニングのための非侵襲的方法 Active JP7727970B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382597 2019-07-15
EP19382597.3 2019-07-15
PCT/EP2020/069918 WO2021009184A1 (en) 2019-07-15 2020-07-14 Non-invasive method for the diagnosis or screening of colorectal cancer and/or pre-cancerous stage thereof

Publications (3)

Publication Number Publication Date
JP2022541169A JP2022541169A (ja) 2022-09-22
JP2022541169A5 true JP2022541169A5 (https=) 2023-07-24
JP7727970B2 JP7727970B2 (ja) 2025-08-22

Family

ID=67480120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502110A Active JP7727970B2 (ja) 2019-07-15 2020-07-14 結腸直腸癌および／またはその前癌段階の診断またはスクリーニングのための非侵襲的方法

Country Status (5)

Country Link
US (1) US20220333205A1 (https=)
EP (1) EP3999663A1 (https=)
JP (1) JP7727970B2 (https=)
AU (1) AU2020315134A1 (https=)
WO (1) WO2021009184A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4130296A1 (en) * 2021-08-03 2023-02-08 Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg Cancer prediction
CN114107514A (zh) * 2022-01-27 2022-03-01 天津欧德莱生物医药科技有限公司 一种用于结直肠癌诊断的miRNA分子标志物及其试剂盒
CN116219019B (zh) * 2023-03-02 2026-01-27 圣湘生物科技股份有限公司 一种用于结直肠癌诊断的microRNA标志物组合物及检测试剂、检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2919064B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal
WO2009111643A2 (en) * 2008-03-06 2009-09-11 Asuragen, Inc. Microrna markers for recurrence of colorectal cancer
US9074206B2 (en) * 2008-11-13 2015-07-07 Fudan University Compositions and methods for micro-RNA expression profiling of colorectal cancer
US20120088687A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
NO3051026T3 (https=) * 2011-10-21 2018-07-28
PL418144A1 (pl) * 2016-07-29 2018-02-12 Gdański Uniwersytet Medyczny Nowy marker obecności mikroprzerzutów i podwyższonego ryzyka nawrotu raka jelita grubego, sposób wykrywania obecności mikroprzerzutów i podwyższonego ryzyka nawrotu raka jelita grubego oraz geny normalizacyjne do normalizacji wyników ekspresji miRNA w tkance raka jelita grubego

Similar Documents

Publication Publication Date Title
AU2011291599B2 (en) Circulating biomarkers for disease
US20140141986A1 (en) Circulating biomarkers
JP2018504609A5 (https=)
RU2014120427A (ru) Определение микрорнк в плазме для обнаружения ранних стадий колоректального рака
WO2011127219A1 (en) Circulating biomarkers for disease
JP2022541169A5 (https=)
US10724097B2 (en) Methods and compositions for diagnosis and management of diabetes and metabolic syndrome
CN107475258B (zh) 一种RNA circEPSTI1及其在三阴乳腺癌上的应用
JP2019527361A (ja) 大腸癌の併用検査
JP2016500821A5 (https=)
JP2021523379A5 (https=)
CN112534068A (zh) 使用液体活检多种癌基因生物标志物的乳腺癌早期诊断及治疗后监测的方法
JP2022522803A5 (https=)
JP2016519767A5 (https=)
CA2623653A1 (en) Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis
Madkour et al. Designing and fabrication of BIRC5-mRNA-based biosensor for early breast cancer diagnosis using a nanostructured (CeO2-Ru@ AuNPs-CNTs)-lab-on-chip
KR20230015047A (ko) 방사선 피폭 진단용 바이오마커 조성물 및 이를 이용한 방사선 피폭 진단을 위한 정보를 제공하는 방법
JP6800470B2 (ja) ｍｉＲＮＡをマーカーとする歯周炎検査キット、及び検査方法
TWI571514B (zh) 評估罹患大腸直腸癌風險的方法
Zhang et al. Unraveling the Microenvironment and the Pathogenic Axis of HIF‐1α–Visfatin–Fibrosis in Autoimmune Pancreatitis Using a Single‐Cell Atlas
TWI404931B (zh) 癌化生物樣本之檢測方法及其使用之檢驗試劑
ES2891795T3 (es) Procedimiento y kit para el diagnóstico de cáncer colorrectal
WO2013191242A1 (ja) 予後不良の肺小細胞がんの検査方法及び治療手段
WO2022197659A2 (en) Fluorescence detection of circulating cell free dna including within extracellualr vesicles in biospecimens and liquid biopsies
Zhang et al. A Corrective Method for Different Hematocrit Values of Whole Blood Samples on the Detection of Procalcitonin.